Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Global, Regional, and National Burden of Respiratory Tract Cancers and Associated Risk Factors From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019 Publisher Pubmed



Ebrahimi H1 ; Aryan Z1, 6 ; Saeedi Moghaddam S1 ; Bisignano C8 ; Rezaei S1, 10 ; Pishgar F1 ; Force LM8, 11 ; Abolhassani H2, 12 ; Abugharbieh E13 ; Advani SM14, 15 ; Ahmad S16 ; Alahdab F17 ; Alipour V18, 19, 160 ; Aljunid SM22, 23 Show All Authors
Authors
  1. Ebrahimi H1
  2. Aryan Z1, 6
  3. Saeedi Moghaddam S1
  4. Bisignano C8
  5. Rezaei S1, 10
  6. Pishgar F1
  7. Force LM8, 11
  8. Abolhassani H2, 12
  9. Abugharbieh E13
  10. Advani SM14, 15
  11. Ahmad S16
  12. Alahdab F17
  13. Alipour V18, 19, 160
  14. Aljunid SM22, 23
  15. Amini S24
  16. Ancuceanu R27
  17. Andrei CL28
  18. Andrei T30
  19. Arabloo J18
  20. Arabzozani M31
  21. Asaad M32
  22. Ausloos M30, 33
  23. Awedew AF34
  24. Baig AA35
  25. Bijani A36
  26. Biondi A37
  27. Bjorge T38, 39
  28. Braithwaite D40, 41
  29. Brauer M8, 42
  30. Brenner H43
  31. Bustamanteteixeira MT44
  32. Butt ZA45, 46
  33. Carreras G48
  34. Castanedaorjuela CA49, 50
  35. Chimedochir O51
  36. Chu DT52
  37. Chung MT53
  38. Cohen AJ8, 54
  39. Compton K8
  40. Dagnew B55
  41. Dai X8
  42. Dandona L8, 58, 59
  43. Dandona R8, 9, 58
  44. Dean FE8
  45. Derbew Molla M56
  46. Desta AA57
  47. Driscoll TR60
  48. Faraon EJA62
  49. Faris PS63, 64
  50. Filip I65, 66
  51. Fischer F67
  52. Fu W8
  53. Gallus S68
  54. Gebregiorgis BG69
  55. Ghashghaee A18, 20
  56. Golechha M70
  57. Gonfa KB71
  58. Gorini G47
  59. Goulart BNG72
  60. Guerra MR44
  61. Hafezinejad N3, 73
  62. Hamidi S74
  63. Hay SI8, 9
  64. Herteliu C30, 75
  65. Hoang CL76
  66. Horita N77, 78
  67. Hostiuc M29
  68. Househ M79
  69. Iavicoli I80
  70. Ilic IM81
  71. Ilic MD83
  72. Irvani SSN84
  73. Islami F86
  74. Kamath A87, 88
  75. Kaur S89
  76. Khalilov R90, 91
  77. Khan EA92
  78. Kocarnik JM8, 93
  79. Kucuk Bicer B94
  80. Kumar GA58
  81. La Vecchia C95
  82. Lan Q96
  83. Landires I97, 100
  84. Lasrado S101
  85. Lauriola P102
  86. Leong E103
  87. Li B104
  88. Lim SS8, 9
  89. Lopez AD8, 9, 105
  90. Majeed A107
  91. Malekzadeh R4, 109
  92. Manafi N21, 110
  93. Menezes RG111
  94. Miazgowski T113
  95. Misra S114
  96. Mohammadianhafshejani A115
  97. Mohammed S116, 117
  98. Mokdad AH8, 9
  99. Molassiotis A118
  100. Monasta L119
  101. Moradzadeh R25
  102. Morawska L120
  103. Morgadodacosta J121
  104. Morrison SD122
  105. Naimzada MD123, 124
  106. Nazari J26
  107. Nguyen CT125
  108. Nguyen HLT125
  109. Nikbakhsh R85
  110. Nunezsamudio V98, 99
  111. Olagunju AT126, 127
  112. Otstavnov N123
  113. Otstavnov SS123, 128
  114. Mahesh PA129
  115. Pana A30, 130
  116. Park EK131
  117. Pottoo FH112
  118. Pourshams A4
  119. Rabiee M132
  120. Rabiee N133
  121. Radfar A134
  122. Rafiei A135, 136
  123. Rahman MA138, 139
  124. Ram P140
  125. Rathi P87
  126. Rawaf DL108, 141
  127. Rawaf S107, 142
  128. Rezaei N2, 143
  129. Roberts NLS144
  130. Roberts TJ145
  131. Ronfani L119
  132. Roshandel G146
  133. Samy AM147
  134. Santricmilicevic MM81, 82
  135. Sathian B148, 149
  136. Schneider IJC150
  137. Sekerija M151, 152
  138. Sepanlou SG4, 109
  139. Sha F153
  140. Shaikh MA154
  141. Sharma R155
  142. Sheikh A7, 156
  143. Sheikhbahaei S73
  144. Siddappa Malleshappa SK157
  145. Singh JA158, 159
  146. Sitas F61, 161
  147. Spurlock EE8
  148. Steiropoulos P162
  149. Tabaresseisdedos R163, 164
  150. Tadesse EG165
  151. Takahashi K166
  152. Traini E167
  153. Tran BX168
  154. Tran KB169, 170
  155. Travillian RS8
  156. Vacante M37
  157. Villeneuve PJ171
  158. Violante FS172, 173
  159. Yousefi Z137
  160. Yuce D174
  161. Zadnik V175
  162. Zamanian M25
  163. Zendehdel K5
  164. Zhang J106, 176
  165. Zhang ZJ177
  166. Farzadfar F1
  167. Murray CJL8, 9
  168. Naghavi M8, 9

Source: The Lancet Respiratory Medicine Published:2021


Abstract

Background Prevention, control, and treatment of respiratory tract cancers are important steps towards achieving target 3.4 of the UN Sustainable Development Goals (SDGs)—a one-third reduction in premature mortality due to non-communicable diseases by 2030. We aimed to provide global, regional, and national estimates of the burden of tracheal, bronchus, and lung cancer and larynx cancer and their attributable risks from 1990 to 2019. Methods Based on the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 methodology, we evaluated the incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) of respiratory tract cancers (ie, tracheal, bronchus, and lung cancer and larynx cancer). Deaths from tracheal, bronchus, and lung cancer and larynx cancer attributable to each risk factor were estimated on the basis of risk exposure, relative risks, and the theoretical minimum risk exposure level input from 204 countries and territories, stratified by sex and Socio-demographic Index (SDI). Trends were estimated from 1990 to 2019, with an emphasis on the 2010-19 period. Findings Globally, there were 2·26 million (95% uncertainty interval 2·07 to 2·45) new cases of tracheal, bronchus, and lung cancer, and 2·04 million (1·88 to 2·19) deaths and 45·9 million (42·3 to 49·3) DALYs due to tracheal, bronchus, and lung cancer in 2019. There were 209 000 (194 000 to 225 000) new cases of larynx cancer, and 123 000 (115 000 to 133 000) deaths and 3·26 million (3·03 to 3·51) DALYs due to larynx cancer globally in 2019. From 2010 to 2019, the number of new tracheal, bronchus, and lung cancer cases increased by 23·3% (12·9 to 33·6) globally and the number of larynx cancer cases increased by 24·7% (16·0 to 34·1) globally. Global age-standardised incidence rates of tracheal, bronchus, and lung cancer decreased by 7·4% (−16·8 to 1·6) and age-standardised incidence rates of larynx cancer decreased by 3 ·0% (−10·5 to 5·0) in males over the past decade; however, during the same period, age-standardised incidence rates in females increased by 0·9% (−8·2 to 10·2) for tracheal, bronchus, and lung cancer and decreased by 0·5% (−8·4 to 8·1) for larynx cancer. Furthermore, although age-standardised incidence and death rates declined in both sexes combined from 2010 to 2019 at the global level for tracheal, bronchus, lung and larynx cancers, some locations had rising rates, particularly those on the lower end of the SDI range. Smoking contributed to an estimated 64·2% (61·9–66·4) of all deaths from tracheal, bronchus, and lung cancer and 63·4% (56·3–69·3) of all deaths from larynx cancer in 2019. For males and for both sexes combined, smoking was the leading specific risk factor for age-standardised deaths from tracheal, bronchus, and lung cancer per 100 000 in all SDI quintiles and GBD regions in 2019. However, among females, household air pollution from solid fuels was the leading specific risk factor in the low SDI quintile and in three GBD regions (central, eastern, and western sub-Saharan Africa) in 2019. Interpretation The numbers of incident cases and deaths from tracheal, bronchus, and lung cancer and larynx cancer increased globally during the past decade. Even more concerning, age-standardised incidence and death rates due to tracheal, bronchus, lung cancer and larynx cancer increased in some populations—namely, in the lower SDI quintiles and among females. Preventive measures such as smoking control interventions, air quality management programmes focused on major air pollution sources, and widespread access to clean energy should be prioritised in these settings. © 2021. All Rights Reserved.
Other Related Docs